Lupin Pharmaceuticals announced a recall of the chewable pills, sold under the name Mibelas 24 F-E, on May 29. The pills were packaged in a way that reversed the tablets’ order, meaning that the first four pills were non-hormonal placebos rather than the active tablets they were supposed to be.
“As a result of this packaging error, oral contraceptive tablets that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy,” the FDA’s statement reads.
The FDA warns that the packaging error also means taking the pills could cause “significant” harm to both maternal and fetal health. However, at the time of writing, no such adverse events have been reported.
The pills, which are packaged in blister packs containing 28 tablets, were distributed nationwide in the U.S. to wholesalers, clinics and retail pharmacies. Consumers who have the product are advised to return the product to the pharmacy or place of purchase, as well as contact their healthcare provider if they have experienced any adverse effects.
Consumers who have questions about the recall can call the manufacturer, Lupin Pharmaceuticals, at 800-399-2561.
- Yes, Climate Change Is Making Storms Like Hurricane Ian Worse
- 2022 Time100 NEXT: TIME’s List Of Emerging Leaders Who Are Shaping the Future
- Industrial Farming Causes Climate Change. The ‘Slow Food’ Movement Wants to Stop It
- What Reading 220 History Textbooks Taught One Scholar About Racism in America
- Artist Oliver Jeffers Wants to Paint the World Out of a Corner
- A Vibrant North Korean Community in London Finds Its Days Are Numbered
- COVID-19 Vaccines Can Make Periods Longer, Study Says
- Column: What Happened When My Entire Family Came Out
- How DeSantis Handles Hurricane Ian Will Shape His Political Future